Christopher W. Fulton

Array ( [id] => 6175749 [patent_doc_number] => 20020155455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Highly homogeneous molecular markers for electrophoresis' [patent_app_type] => new [patent_app_number] => 09/927436 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14599 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155455.pdf [firstpage_image] =>[orig_patent_app_number] => 09927436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1210335 [patent_doc_number] => 06713633 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Compounds capable of cleaving double-stranded DNA and method of utilization of the same' [patent_app_type] => B1 [patent_app_number] => 09/701264 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4135 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713633.pdf [firstpage_image] =>[orig_patent_app_number] => 09701264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127325 [patent_doc_number] => 06790935 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Cyclosporin derivatives and method for the production of said derivatives' [patent_app_type] => B1 [patent_app_number] => 09/890636 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2640 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790935.pdf [firstpage_image] =>[orig_patent_app_number] => 09890636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409926 [patent_doc_number] => 20020038026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Method of synthesizing diketopiperazines' [patent_app_type] => new [patent_app_number] => 09/922604 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038026.pdf [firstpage_image] =>[orig_patent_app_number] => 09922604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668426 [patent_doc_number] => 20030113409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Tellurium containing nutrient formulation and process for enhancing the cumulative weight gain or feed efficacy in poultry' [patent_app_type] => new [patent_app_number] => 09/918865 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4796 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113409.pdf [firstpage_image] =>[orig_patent_app_number] => 09918865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779164 [patent_doc_number] => 20030050246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Peptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 09/915956 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17691 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050246.pdf [firstpage_image] =>[orig_patent_app_number] => 09915956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361298 [patent_doc_number] => 20020058629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'S-nitrosothiols as agents for the treatment of circulatory dysfunctions' [patent_app_type] => new [patent_app_number] => 09/912164 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7783 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058629.pdf [firstpage_image] =>[orig_patent_app_number] => 09912164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193158 [patent_doc_number] => 06730660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-04 [patent_title] => 'Peritoneal dialysis solutions with polypeptides' [patent_app_type] => B2 [patent_app_number] => 09/909733 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6202 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730660.pdf [firstpage_image] =>[orig_patent_app_number] => 09909733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558435 [patent_doc_number] => 07157430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => '(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases' [patent_app_type] => utility [patent_app_number] => 09/912674 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35986 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157430.pdf [firstpage_image] =>[orig_patent_app_number] => 09912674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073810 [patent_doc_number] => 06838475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 09/909077 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11797 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838475.pdf [firstpage_image] =>[orig_patent_app_number] => 09909077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127636 [patent_doc_number] => 06790989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-14 [patent_title] => 'Inhibitors of the ICE/ced-3 family of cysteine proteases' [patent_app_type] => B2 [patent_app_number] => 09/908969 [patent_app_country] => US [patent_app_date] => 2001-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16863 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 988 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790989.pdf [firstpage_image] =>[orig_patent_app_number] => 09908969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990933 [patent_doc_number] => 20050089970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use' [patent_app_type] => utility [patent_app_number] => 10/332039 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 41839 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089970.pdf [firstpage_image] =>[orig_patent_app_number] => 10332039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142430 [patent_doc_number] => 20020002268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides' [patent_app_type] => new [patent_app_number] => 09/903813 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12421 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002268.pdf [firstpage_image] =>[orig_patent_app_number] => 09903813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7603347 [patent_doc_number] => 07235685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Aromatic sulfenates for type I phototherapy' [patent_app_type] => utility [patent_app_number] => 09/898887 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4676 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235685.pdf [firstpage_image] =>[orig_patent_app_number] => 09898887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454582 [patent_doc_number] => 06462174 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Amorphous compound' [patent_app_type] => B1 [patent_app_number] => 09/891035 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5633 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462174.pdf [firstpage_image] =>[orig_patent_app_number] => 09891035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467220 [patent_doc_number] => 06458769 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Amorphous compound' [patent_app_type] => B1 [patent_app_number] => 09/891860 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5631 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458769.pdf [firstpage_image] =>[orig_patent_app_number] => 09891860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987428 [patent_doc_number] => 20020099042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Inhibitors of interleukin-1 beta converting enzyme' [patent_app_type] => new [patent_app_number] => 09/886773 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56879 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099042.pdf [firstpage_image] =>[orig_patent_app_number] => 09886773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240637 [patent_doc_number] => 06686446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Methods and compositions for controlled polypeptide synthesis' [patent_app_type] => B2 [patent_app_number] => 09/877957 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 36434 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686446.pdf [firstpage_image] =>[orig_patent_app_number] => 09877957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096625 [patent_doc_number] => 20020052323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents' [patent_app_type] => new [patent_app_number] => 09/870027 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17143 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052323.pdf [firstpage_image] =>[orig_patent_app_number] => 09870027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278530 [patent_doc_number] => 20020107204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for reducing or preventing the establishment, growth or metastasis of cancer by administering benzimidazolone peptidomimetics PAR-1 antagonist and optionally PAR-2 \n antagonists' [patent_app_type] => new [patent_app_number] => 09/865285 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20657 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107204.pdf [firstpage_image] =>[orig_patent_app_number] => 09865285 [rel_patent_id] =>[rel_patent_doc_number] =>)